Metraipolis › archive › dc_c41c09fa4d24

Obinutuzumab maintenance versus observation for patients with newly diagnosed high tumor burden follicular lymphoma who achieved complete metabolic response… — Europe PMC PMID:39997358

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/39997358
DOI
10.1093/jjco/hyaf038
License (as archived)
solo-consultazione
Archived
2026-10-07T20:06:30.636Z
SHA-256 of the archived text
e22d4352fbb4d3262cae0d656846e095e851943283675f2cdec4180e3a9a0aa6
Stable URL of this page
https://metraipolis.com/documento/dc_c41c09fa4d24

How to cite

Obinutuzumab maintenance versus observation for patients with newly diagnosed high tumor burden follicular lymphoma who achieved complete metabolic response… — Europe PMC PMID:39997358 — Europe PMC (en), https://europepmc.org/article/MED/39997358 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c41c09fa4d24 (Metraipolis archive dc_c41c09fa4d24, sha256 e22d4352fbb4d3262cae0d656846e095e851943283675f2cdec4180e3a9a0aa6)
BibTeX
@misc{dcc41c09fa4d24,
  title = {Obinutuzumab maintenance versus observation for patients with newly diagnosed high tumor burden follicular lymphoma who achieved complete metabolic response… — Europe PMC PMID:39997358},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39997358},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c41c09fa4d24; sha256 e22d4352fbb4d3262cae0d656846e095e851943283675f2cdec4180e3a9a0aa6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39997358. Agents can read the archived copy with the MCP tool read_document.